EP Patent

EP1056742A1 — Anti-viral pyrimidine derivatives

Assigned to Tularik Inc · Expires 2000-12-06 · 25y expired

What this patent protects

Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

USPTO Abstract

Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

Drugs covered by this patent

Patent Metadata

Patent number
EP1056742A1
Jurisdiction
EP
Classification
—
Expires
2000-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Tularik Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.